# EGG PHOSPHOLIPIDS

URL: https://app.greenveil.ai/ingredients/ingredient_unii_1_z74184_rgv
Categories: pharma
Identifier: drug bank:DB14233

> EGG PHOSPHOLIPIDS. Route: INTRAVENOUS; Dosage form: EMULSION; Potency: 1.2 %w/v Compiled from 4 published data sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: INTRAVENOUS; Dosage form: EMULSION; Potency: 1.2 %w/v

## Regulatory status

- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: EMULSION; Potency: 1.2 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 1.8 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 12852 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 48.75 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 48 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 25 active drug products and 27 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as concept.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as structurallydiverse.

## Data sources

- FDA Inactive Ingredient Database (updated 2026-01-09): https://www.fda.gov/drugs/drug-approvals-and-databases/inactive-ingredients-database-download
- FDA National Drug Code Directory (updated 2029-02-14): https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory-support-files
- FDA GSRS UNII (updated 2026-02-26): https://precision.fda.gov/uniisearch/
- openFDA Substance (updated 2026-05-24): https://api.fda.gov/other/substance.json?search=unii:1Z74184RGV

_Assessed by Greenveil._